A. Johansen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
A. Johansen has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
O. Pedersen
Faculty of Health Science (O.P.), University of Aarhus, DK-8000 Aarhus, Denmark
3 shared publicationsT. Hansen
Steno Diabetes Center and Hagedorn Research Institute (A.J., J.E., O.P., T.H), DK-2820 Gentofte, Denmark; Glostrup University Hospital (H.B.M.), DK-2600 Glostrup, Denmark
3 shared publicationsD. P. Jensen
Steno Diabetes Center and Hagedorn Research Institute, Gentofte, Copenhagen, Denmark
2 shared publications- Henrik Bindesboel Mortensen
Copenhagen Diabetes Research Center (CPH-DIRECT), Department of Paediatrics, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark
2 shared publications C. Glümer
Steno Diabetes Center and Hagedorn Research Institute
1 shared publicationE.-M. D. Nielsen
Steno Diabetes Center and Hagedorn Research Institute
1 shared publication
Latest Publications
- Open Access
- 1 August 2005
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 90 (8) , 4607-4614
Half of Clinically Defined Maturity-Onset Diabetes of the Young Patients in Denmark Do Not Have Mutations inHNF4A,GCK, andTCF1
Aims/Hypothesis: Maturity-onset diabetes of the young (MODY) is a genetically heterogeneous monogenic form of diabetes characterized by an autosomal dominant inheritance, an early clinical onset, and a primary defect in β-cell function. The aims of the present study were to examine the prevalence and nature of mutations in the three common MODY genes, HNF4A, GCK, and TCF1, in Danish patients with a clinical diagnosis of MODY and to describe metabolic differences in probands with and without mutations in HNF4A, GCK, and TCF1. Methods: Seventy-eight unrelated subjects of Danish Caucasian origin (29 men, 49 women) and their 351 family members were examined. The promotor and coding regions including intron-exon boundaries of HNF4A, GCK, and TCF1 were examined by denaturing HPLC and/or direct sequencing. Results: We identified 29 different mutations in 38 MODY families. Fifteen of the mutations were novel. The variants segregated with diabetes within the families, and none of the variants were found in 100 normal Danish chromosomes. Our findings suggest a relative prevalence of 3% of MODY1 (two different mutations in two families), 10% of MODY2 (seven in eight), and 36% of MODY3 (21 in 28) among Danish kindred clinically diagnosed as MODY. No significant differences in biochemical and anthropometric measurements were observed at baseline examinations. Conclusions: Forty-nine percent of the families carried mutations in the three examined MODY genes. Our findings highlight that unidentified MODY genes may play a central role for diabetes characterized by autosomal dominant transmission. Furthermore, baseline measurements of various anthropometric and biochemical variables are not appropriate markers of MODYX.
- 1 August 2005
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 90 (8) , 4607-4614
Open AccessHalf of Clinically Defined Maturity-Onset Diabetes of the Young Patients in Denmark Do Not Have Mutations inHNF4A,GCK, andTCF1
Aims/Hypothesis: Maturity-onset diabetes of the young (MODY) is a genetically heterogeneous monogenic form of diabetes characterized by an autosomal dominant inheritance, an early clinical onset, and a primary defect in β-cell function. The aims of the present study were to examine the prevalence and nature of mutations in the three common MODY genes, HNF4A, GCK, and TCF1, in Danish patients with a clinical diagnosis of MODY and to describe metabolic differences in probands with and without mutations in HNF4A, GCK, and TCF1. Methods: Seventy-eight unrelated subjects of Danish Caucasian origin (29 men, 49 women) and their 351 family members were examined. The promotor and coding regions including intron-exon boundaries of HNF4A, GCK, and TCF1 were examined by denaturing HPLC and/or direct sequencing. Results: We identified 29 different mutations in 38 MODY families. Fifteen of the mutations were novel. The variants segregated with diabetes within the families, and none of the variants were found in 100 normal Danish chromosomes. Our findings suggest a relative prevalence of 3% of MODY1 (two different mutations in two families), 10% of MODY2 (seven in eight), and 36% of MODY3 (21 in 28) among Danish kindred clinically diagnosed as MODY. No significant differences in biochemical and anthropometric measurements were observed at baseline examinations. Conclusions: Forty-nine percent of the families carried mutations in the three examined MODY genes. Our findings highlight that unidentified MODY genes may play a central role for diabetes characterized by autosomal dominant transmission. Furthermore, baseline measurements of various anthropometric and biochemical variables are not appropriate markers of MODYX.
- 29 March 2005
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 8 (1) , 75-82
IRS1, KCNJ11, PPARγ2 and HNF‐1α : do amino acid polymorphisms in these candidate genes support a shared aetiology between type 1 and type 2 diabetes?
Aims: Type 1 diabetes mellitus (T1DM) is a chronic disorder primarily triggered by environmental and immunological factors in genetically susceptible individuals. Despite the fact that there are indications of common aetiological features of T1DM and type 2 diabetes (T2DM), variation in genes involved in insulin secretion and insulin signalling has to a large extent been ignored as potential modifiers in the pathogenesis of T1DM. Recent studies suggest, however, that proven T2DM susceptibility gene variants may be involved in the pathogenesis of T1DM. The objective of this study was to estimate the impact of four selected amino acid polymorphisms – IRS‐1 Gly972Arg, Kir6.2 Glu23Lys, HNF‐1α Ala98Val and PPARγ2 Pro12Ala in a Danish population of T1DM families. Methods: All variants were genotyped in 490 simplex‐ and multiplex‐T1DM families applying polymerase chain reaction‐restriction fragment length polymorphism, and results were evaluated by means of a transmission disequilibrium test (TDT) analysis. Results: TDT analysis revealed that the Arg972 IRS‐1 , the Lys23 Kir6.2 and the Val98 HNF‐1α variants were transmitted from heterozygous parents to affected probands at frequencies of 49.1%, 47.0% and 54.1%, respectively (p > 0.05 for all). This was similar to the rate of transmission to unaffected siblings. The transmission rate of the Ala12 PPARγ2 variant to affected probands was 46.5% (p > 0.05) which differed significantly from the transmission to unaffected offspring (p = 0.024). A combined analysis of the present and published pertinent data of 1691 transmissions showed a significantly decreased transmission of the PPARγ2 Ala12 allele to affected probands (p = 0.0045). Conclusions: The Pro12Ala variant of PPARγ2 is associated with T1DM, the minor Ala allele conferring a reduced risk. This same finding has been reported in patients with T2DM.
- 29 March 2005
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 8 (1) , 75-82
IRS1, KCNJ11, PPARγ2 and HNF‐1α : do amino acid polymorphisms in these candidate genes support a shared aetiology between type 1 and type 2 diabetes?
Aims: Type 1 diabetes mellitus (T1DM) is a chronic disorder primarily triggered by environmental and immunological factors in genetically susceptible individuals. Despite the fact that there are indications of common aetiological features of T1DM and type 2 diabetes (T2DM), variation in genes involved in insulin secretion and insulin signalling has to a large extent been ignored as potential modifiers in the pathogenesis of T1DM. Recent studies suggest, however, that proven T2DM susceptibility gene variants may be involved in the pathogenesis of T1DM. The objective of this study was to estimate the impact of four selected amino acid polymorphisms – IRS‐1 Gly972Arg, Kir6.2 Glu23Lys, HNF‐1α Ala98Val and PPARγ2 Pro12Ala in a Danish population of T1DM families. Methods: All variants were genotyped in 490 simplex‐ and multiplex‐T1DM families applying polymerase chain reaction‐restriction fragment length polymorphism, and results were evaluated by means of a transmission disequilibrium test (TDT) analysis. Results: TDT analysis revealed that the Arg972 IRS‐1 , the Lys23 Kir6.2 and the Val98 HNF‐1α variants were transmitted from heterozygous parents to affected probands at frequencies of 49.1%, 47.0% and 54.1%, respectively (p > 0.05 for all). This was similar to the rate of transmission to unaffected siblings. The transmission rate of the Ala12 PPARγ2 variant to affected probands was 46.5% (p > 0.05) which differed significantly from the transmission to unaffected offspring (p = 0.024). A combined analysis of the present and published pertinent data of 1691 transmissions showed a significantly decreased transmission of the PPARγ2 Ala12 allele to affected probands (p = 0.0045). Conclusions: The Pro12Ala variant of PPARγ2 is associated with T1DM, the minor Ala allele conferring a reduced risk. This same finding has been reported in patients with T2DM.
- 17 July 2004
- Published by Springer Nature in Diabetologia
- Vol. 47 (8) , 1437-1441
Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion
- 17 July 2004
- Published by Springer Nature in Diabetologia
- Vol. 47 (8) , 1437-1441
Large-scale studies of the functional K variant of the butyrylcholinesterase gene in relation to Type 2 diabetes and insulin secretion